ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schulze-Koops H, Schett G, Spiera R, Unizony SH, Collinson N (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Book Volume: 77

Pages Range: 1120-1121

DOI: 10.1093/rheumatology/kez107.088

Authors with CRIS profile

Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Istituto di ricovero e cura a carattere scientifico (IRCCS)

Italy (IT) Southend Hospital

United Kingdom (GB) Universitat de Barcelona (UB) / University of Barcelona

Spain (ES) University of Groningen / Rijksuniversiteit Groningen

Netherlands (NL) Genentech Inc.

United States (USA) (US) Harvard University

United States (USA) (US) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Belgium (BE) Cornell University

United States (USA) (US) Ludwig-Maximilians-Universität (LMU)

Germany (DE) Roche Products Limited and Roche Diagnostics Limited

United Kingdom (GB)

How to cite

APA:

Stone, J.H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D.,... Collinson, N. (2018). ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL. (pp. 1120-1121).

MLA:

Stone, J. H., et al. "ACUTE PHASE REACTANT LEVELS AND PREDNISONE DOSES AT DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS: PROSPECTIVE DATA FROM THE GIACTA TRIAL." 2018. 1120-1121.

BibTeX: Download